Page last updated: 2024-10-29

amrinone and Intraventricular Septal Defects

amrinone has been researched along with Intraventricular Septal Defects in 2 studies

Amrinone: A positive inotropic cardiotonic (CARDIOTONIC AGENTS) with vasodilator properties, phosphodiesterase 3 inhibitory activity, and the ability to stimulate calcium ion influx into the cardiac cell.
amrinone : A 3,4'-bipyridine substituted at positions 5 and 6 by an amino group and a keto function respectively. A pyridine phosphodiesterase 3 inhibitor, it is a drug that may improve the prognosis in patients with congestive heart failure.

Research Excerpts

ExcerptRelevanceReference
"Amrinone is a bipyridine derivative with inotropic and vasodilator effects that have not been systematically evaluated in the pediatric patient with increased pulmonary blood flow."1.29Selective pulmonary and systemic vasodilator effects of amrinone in children: new therapeutic implications. ( Gelband, H; Mas, MS; Robinson, BW, 1993)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Robinson, BW1
Gelband, H1
Mas, MS1
Boucek, MM1
Chang, R1
Synhorst, DP1

Other Studies

2 other studies available for amrinone and Intraventricular Septal Defects

ArticleYear
Selective pulmonary and systemic vasodilator effects of amrinone in children: new therapeutic implications.
    Journal of the American College of Cardiology, 1993, Volume: 21, Issue:6

    Topics: Amrinone; Blood Pressure; Child; Child, Preschool; Drug Evaluation; Female; Heart Septal Defects, Ve

1993
Hemodynamic consequences of inotropic support with digoxin or amrinone in lambs with ventricular septal defect.
    Pediatric research, 1985, Volume: 19, Issue:9

    Topics: Aminopyridines; Amrinone; Animals; Animals, Newborn; Digoxin; Dose-Response Relationship, Drug; Hear

1985